Specifically, higher vaspin levels were observed in insulin-treated GDM mothers compared to normoglycemic women, suggesting a possible compensatory insulin-sensitizing role in more severe metabolic dysregulation. The gene discussed is SERPINA12; the disease is gestational diabetes.